Literature DB >> 8003796

Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin.

R C Ratnavel1, P G Norris.   

Abstract

Elastosis perforans serpiginosa (EPS) and the elastotic changes of pseudoxanthoma elasticum (PXE) are rare but well-recognized side-effects of long-term penicillamine therapy. A 42-year old female patient who developed both of these cutaneous side-effects following treatment with high-dose penicillamine for Wilson's disease is described; near-complete resolution of the EPS, but not the PXE was achieved by treatment with isotretinoin (0.5 mg/kg/day) for 6 weeks, despite continuation of the penicillamine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003796     DOI: 10.1159/000246792

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  5 in total

1.  Elastosis perforans serpiginosa in association with scabies mite.

Authors:  Michael Kassardjian; Julie Frederickson; Jack Griffith; Paul Shitabata; David Horowitz
Journal:  J Clin Aesthet Dermatol       Date:  2013-10

2.  Elastosis perforans serpiginosa.

Authors:  Ludimila Noleto de Rezende; Mónica Gauto Nuñez; Thaís Genn Clavery; Eneida Genn Constancio; Mayra Carrijo Rochael; Gabriela Juncá T Pires; Omar Lupi
Journal:  Indian Dermatol Online J       Date:  2014-04

3.  Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream.

Authors:  Pernille Axél Gregersen; Birgitte Stausbøl-Grøn; Mette Ramsing; Mette Sommerlund
Journal:  Dermatol Reports       Date:  2010-10-29

4.  D-penicillamine-induced pseudo-pseudoxanthoma elasticum and extensive elastosis perforans serpiginosa with excellent response to acitretin.

Authors:  Muzamil Amin Chisti; Yousef Binamer; Abdullah Alfadley; Abdulmonem Almutawa
Journal:  Ann Saudi Med       Date:  2019 Jan-Feb       Impact factor: 1.526

5.  The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification.

Authors:  Georges Lefthériotis; Loukman Omarjee; Olivier Le Saux; Daniel Henrion; Pierre Abraham; Fabrice Prunier; Serge Willoteaux; Ludovic Martin
Journal:  Front Genet       Date:  2013-02-12       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.